GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.75 $4.97 Wednesday, 17th Apr 2024 ALDX stock ended at $3.97. This is 2.58% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 8.22% from a day low at $3.83 to a day high of $4.15.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2023-12-28 $3.63 $3.77 $3.51 $3.61 918 210
2023-12-27 $3.44 $3.71 $3.42 $3.63 1 229 637
2023-12-26 $3.55 $3.55 $3.34 $3.44 650 743
2023-12-22 $3.47 $3.64 $3.40 $3.48 1 150 858
2023-12-21 $3.37 $3.53 $3.27 $3.35 1 068 072
2023-12-20 $3.34 $3.71 $3.25 $3.36 2 096 054
2023-12-19 $3.44 $3.58 $3.06 $3.51 10 693 025
2023-12-18 $3.06 $3.16 $2.95 $2.96 796 884
2023-12-15 $2.99 $3.10 $2.93 $3.02 4 685 651
2023-12-14 $3.13 $3.26 $2.93 $2.98 1 643 884
2023-12-13 $2.86 $3.08 $2.73 $3.08 1 231 198
2023-12-12 $2.92 $2.95 $2.75 $2.87 1 133 125
2023-12-11 $3.18 $3.18 $2.84 $2.85 1 122 619
2023-12-08 $3.22 $3.34 $3.15 $3.16 783 093
2023-12-07 $3.18 $3.26 $3.13 $3.24 600 489
2023-12-06 $3.21 $3.25 $3.05 $3.15 812 496
2023-12-05 $3.28 $3.36 $3.09 $3.12 1 286 639
2023-12-04 $2.84 $3.37 $2.84 $3.27 2 117 978
2023-12-01 $2.82 $2.90 $2.69 $2.86 905 060
2023-11-30 $2.77 $2.90 $2.77 $2.77 1 687 366
2023-11-29 $2.69 $2.96 $2.69 $2.77 1 107 997
2023-11-28 $2.52 $2.73 $2.47 $2.70 1 439 810
2023-11-27 $2.50 $2.63 $2.43 $2.62 1 001 976
2023-11-24 $2.59 $2.65 $2.51 $2.53 427 560
2023-11-22 $2.45 $2.62 $2.45 $2.53 938 847
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT